Investigational Site Number :3480003
Kaposvár 7400
1 studies enrolling now · 3 studies all time
What they study most
Breast Cancer, Hidradenitis Suppurativa, Plasma Cell Myeloma Recurrent
Studies at this site
- A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Recruiting now
- SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
- Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early